Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
Frequently asked questions (FAQs) Which GLP-1 can be taken orally
patients receiving ADMs saw noticeable spikes in the rate of discontinuation due to medication availability in January 2023 (5.3%) and June 2024 (4.8%), while patients receiving AOMs experienced higher rates of discontinuation due to medication availability throughout 2023 and into early 2024
As the healthcare landscape continues to evolve, tools like dosage calculators will likely play an increasingly vital role in ensuring safe and effective medication management
But, as of yet, there is no validated advice from health authorities or drug manufacturers on how to reduce your GLP-1 dose safely and effectively to maintain a steady weight
Choosing a clinician-guided path ensures that your treatment plan is constantly monitored and safely adjusted to match your individual metabolic rate
